跳到正文
原文
Nature 健康护理主题·· 15 天前AI 评分35

晶体酚治疗复发性尾窦炎的短期临床结果:一项前瞻性非对照队列研究

Short-term clinical outcomes following crystallized phenol treatment for recurrent pilonidal sinus: a prospective uncontrolled cohort study

AI 导读

本研究描述了31例复发性尾窦炎患者接受晶体酚治疗后的伤口愈合、术后症状和疼痛评分。18例(58.1%)患者在4周内完全愈合,另有11例在4周后愈合。术后疼痛评分逐渐下降,但缺乏对照组,无法得出特定的镇痛效果结论。需更大规模的对照研究以评估疗效和安全性。

正文

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Crystallized phenol is used as a minimally invasive treatment for pilonidal sinus disease. Evidence describing short-term outcomes in patients with recurrent disease remains limited. This study describes wound healing, postoperative symptoms, and pain scores after crystallized phenol treatment in a small uncontrolled cohort. This prospective uncontrolled cohort included 31 patients with recurrent pilonidal sinus following previous surgery. All patients received crystallized phenol treatment. Complete healing was defined as closure of the sinus opening and cessation of discharge. Healing within four weeks was examined as an exploratory descriptive category because this threshold was not prespecified. Pain was assessed using a visual analogue scale (VAS) on the day after treatment and at weeks 1 and 2. No pretreatment VAS measurement or concurrent control group was available. Complete healing within four weeks was documented in 18/31 patients (58.1%); 11 (35.5%) healed after four weeks and 2 (6.5%) had no documented healing. Pruritus was reported by 28 patients (90.3%) and burning sensation by 9 (29.0%); no abscess or collection was documented during follow-up. Mean postoperative VAS scores were 3.81 ± 1.37 on the day after treatment, 1.13 ± 0.84 at week 1, and 0.84 ± 0.82 at week 2. These observations describe postoperative pain over time and do not establish a phenol-specific analgesic effect. This small uncontrolled cohort provides a descriptive account of short-term outcomes after crystallized phenol treatment for recurrent pilonidal sinus. The observed postoperative decline in VAS scores cannot be attributed specifically to phenol, and conclusions about comparative effectiveness and safety are limited by the lack of a control group and incomplete characterization of adverse events. Larger comparative studies with standardized outcome assessment and longer follow-up are needed.

Trial registration Iranian Registry of Clinical Trials (IRCT), IRCT20130826014483N13. Registered on 2025–08-05. URL: https://www.irct.ir/search/result?query=IRCT20130826014483N13

Acknowledgements

The authors sincerely thank the officials and research staff of the Faculty of Medicine, Mazandaran University of Medical Sciences, for their support and valuable contributions to this study.

Funding

This study did not receive any financial support for study design, data collection, analysis, interpretation, or manuscript preparation.

Author information

Authors and Affiliations

  1. Department of Surgery, Clinical Research Development Unit of Imam Khomeini Hospital, Mazandaran University of Medical Science, Sari, Iran

    Mina Alvandipour, Sohrab Sayyadi & Fereshteh Khandel

  2. Biostatistics Department, School of Health, Health Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran

    Jamshid Yazdani-Charati

  3. Department of Surgery, School of Medicine Imam, Khomeini Hospital Mazandaran University of Medical Sciences, Sari, Iran

    Fereshteh Khandel

Authors

  1. Mina Alvandipour
  2. Sohrab Sayyadi
  3. Fereshteh Khandel
  4. Jamshid Yazdani-Charati

Corresponding author

Correspondence to Fereshteh Khandel.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

This prospective uncontrolled cohort study was conducted in accordance with the Declaration of Helsinki and applicable national research regulations. The study protocol was approved by the Ethics Committee of Mazandaran University of Medical Sciences (IR.MAZUMS.IMAMHOSPITAL.REC.1404.033). All participants received written and verbal information about the study and provided written informed consent. Participation was voluntary, and patients could withdraw at any time without affecting their standard care. Confidentiality was maintained through data anonymization and secure storage. The study is registered in the Iranian Registry of Clinical Trials under identifier IRCT20130826014483N13. The official registration date and the timing of registration relative to first participant enrollment must be verified against the registry record before resubmission. The study is not described as randomized because no random allocation or comparison group is reported.

Consent for publication

Not applicable. No individual patient data or identifiable images are included in this manuscript.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alvandipour, M., Sayyadi, S., Khandel, F. et al. Short-term clinical outcomes following crystallized phenol treatment for recurrent pilonidal sinus: a prospective uncontrolled cohort study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-78204-y

Download citation

  • Received: 25 May 2026

  • Accepted: 26 October 2026

  • Published: 06 November 2026

  • DOI: https://doi.org/10.1038/s41598-026-78204-y

Keywords

来源:Nature 健康护理主题 · nature.com